ValiRx plc (LON:VAL – Get Free Report)’s share price traded up 17.4% on Tuesday . The stock traded as high as GBX 0.50 ($0.01) and last traded at GBX 0.50 ($0.01). 10,318,630 shares changed hands during mid-day trading, an increase of 33% from the average session volume of 7,762,516 shares. The stock had previously closed at GBX 0.43 ($0.01).
ValiRx Trading Down 1.0 %
The company’s 50 day simple moving average is GBX 0.61 and its two-hundred day simple moving average is GBX 1. The company has a market cap of £1.97 million, a PE ratio of -0.35 and a beta of 0.59. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.65 and a quick ratio of 1.27.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Read More
- Five stocks we like better than ValiRx
- Transportation Stocks Investing
- Joby Aviation: Operational Momentum vs. Market Sentiment
- Industrial Products Stocks Investing
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- How to Read Stock Charts for Beginners
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.